NASDAQ: CKPT
Checkpoint Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for CKPT

Based on 3 analysts offering 12 month price targets for Checkpoint Therapeutics Inc

Min Forecast
$4.10+0%
Avg Forecast
$4.33+5.68%
Max Forecast
$4.80+17.07%

Should I buy or sell CKPT stock?

Based on 3 analysts offering ratings for Checkpoint Therapeutics Inc.

Buy
Strong Buy
1 analysts 33.33%
Buy
0 analysts 0%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CKPT stock forecasts and price targets.

CKPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-31
lockedlocked$00.00+00.00%2025-03-11
lockedlocked$00.00+00.00%2025-03-10

1 of 1

Forecast return on equity

Is CKPT forecast to generate an efficient return?

Company
N/A
Industry
146.26%
Market
80.85%

Forecast return on assets

Is CKPT forecast to generate an efficient return on assets?

Company
N/A
Industry
36.38%

CKPT earnings per share forecast

What is CKPT's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$0.14

CKPT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CKPT$4.10$4.33+5.68%Buy
OLMA$5.04$27.67+448.95%Strong Buy
ARCT$12.82$54.75+327.07%Strong Buy
AUTL$1.31$9.32+611.45%Strong Buy
RIGL$19.57$36.80+88.04%Buy

Checkpoint Therapeutics Stock Forecast FAQ

Is Checkpoint Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CKPT) stock is to Buy CKPT stock.

Out of 3 analysts, 1 (33.33%) are recommending CKPT as a Strong Buy, 0 (0%) are recommending CKPT as a Buy, 2 (66.67%) are recommending CKPT as a Hold, 0 (0%) are recommending CKPT as a Sell, and 0 (0%) are recommending CKPT as a Strong Sell.

If you're new to stock investing, here's how to buy Checkpoint Therapeutics stock.

What is CKPT's earnings growth forecast for 2025-2025?

(NASDAQ: CKPT) Checkpoint Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.73%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.6%.

Checkpoint Therapeutics's earnings in 2025 is -$56,240,000.

In 2025, CKPT is forecast to generate $11,726,923 in earnings, with the lowest earnings forecast at $11,726,923 and the highest earnings forecast at $11,726,923.

What is CKPT's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CKPT) forecast ROE is N/A, which is considered weak.

What is CKPT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CKPT price target, the average CKPT price target is $4.33, with the highest CKPT stock price forecast at $4.80 and the lowest CKPT stock price forecast at $4.10.

On average, Wall Street analysts predict that Checkpoint Therapeutics's share price could reach $4.33 by Mar 31, 2026. The average Checkpoint Therapeutics stock price prediction forecasts a potential upside of 5.68% from the current CKPT share price of $4.10.

What is CKPT's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: CKPT) Checkpoint Therapeutics's current Earnings Per Share (EPS) is -$1.42. In 2025, CKPT's EPS is forecast to hit $0.14 (min: $0.14, max: $0.14).

What is CKPT's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CKPT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 36.38%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.